Literature DB >> 7948561

Aeromonas species in septicemia: laboratory characteristics and clinical observations.

J M Janda1, L S Guthertz, R P Kokka, T Shimada.   

Abstract

We retrospectively analyzed clinical and epidemiological data on and laboratory characteristics of 53 cases of aeromonas septicemia. Only four Aeromonas genomospecies (species defined by DNA relatedness) were associated with the 53 cases, with Aeromonas hydrophila (sensu stricto) predominating (47%). Nearly 60% of all Aeromonas isolates from blood fell into one of four somatic groups: serogroups O:11, O:16, O:18, and O:34. Unlike Aeromonas-associated gastroenteritis, septicemia did not peak in frequency during the warmer months but rather was most common in January through March, when approximately 40% of cases occurred. In vitro tests of the pathogenicity of 20 selected blood isolates of Aeromonas indicated that resistance to complement-mediated lysis, elevated levels of protease and hemolysin activity, and the ability to elaborate siderophores correlated with higher virulence. Species and serogroup designations also correlated with the degree of virulence. Susceptibility studies of 50 strains indicated that A. hydrophila was the most drug-resistant species and that Aeromonas veronii was the most susceptible. Susceptibility to first- and second-generation cephalosporins and carbenicillin was species-associated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948561     DOI: 10.1093/clinids/19.1.77

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  47 in total

1.  Identification of motile Aeromonas strains with the MicroScan WalkAway system in conjunction with the combo negative type 1S panels.

Authors:  J Vivas; A I Sáa; A Tinajas; L Barbeyto; L A Rodríguez
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

2.  Purification and characterization of the N-terminal domain of ExeA: a novel ATPase involved in the type II secretion pathway of Aeromonas hydrophila.

Authors:  Ian C Schoenhofen; Gang Li; Timothy G Strozen; S Peter Howard
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

3.  Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe.

Authors:  Patrick Hochedez; Emilie Hope-Rapp; Claude Olive; Muriel Nicolas; Gilles Beaucaire; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

4.  Prospective nationwide study of Aeromonas infections in France.

Authors:  Brigitte Lamy; Angeli Kodjo; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

5.  Bioconversion of α-chitin into N-acetyl-glucosamine using chitinases produced by marine-derived Aeromonas caviae isolates.

Authors:  Flávio Augusto Cardozo; Juan Miguel Gonzalez; Valker Araujo Feitosa; Adalberto Pessoa; Irma Nelly Gutierrez Rivera
Journal:  World J Microbiol Biotechnol       Date:  2017-10-27       Impact factor: 3.312

6.  Characterization of Aeromonas virulence using an immunocompromised mouse model.

Authors:  Dennis J Lye; Mark R Rodgers; Gerard Stelma; Stephen J Vesper; Samuel L Hayes
Journal:  Curr Microbiol       Date:  2007-03       Impact factor: 2.188

7.  Symbiosis of Aeromonas veronii biovar sobria and Hirudo medicinalis, the medicinal leech: a novel model for digestive tract associations.

Authors:  J Graf
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

8.  Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing.

Authors:  S Merino; X Rubires; A Aguilar; S Albertí; S Hernandez-Allés; V J Benedí; J M Tomas
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  Further studies on biochemical characteristics and serologic properties of the genus Aeromonas.

Authors:  J M Janda; S L Abbott; S Khashe; G H Kellogg; T Shimada
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

10.  A type III secretion system is required for Aeromonas hydrophila AH-1 pathogenesis.

Authors:  H B Yu; P S Srinivasa Rao; H C Lee; S Vilches; S Merino; J M Tomas; K Y Leung
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.